SeekingAlpha · Sep 8, 2026
Outsize Transaction Moves Private Equity Pharma Deals To $17.8B
In July alone, the sector recorded a total transaction value of $3.74 billion, topping the second quarter's $3.21 billion.
GB
OTC · GBLBY
Groupe Bruxelles Lambert S.A.
Financial Services · Asset Management
$8.49
Down-$0.15 (-1.74%)
Updated Sep 18, 2026, 5:11 PM
SID Score
5.2/10
Composite research score
Smart Money
46/100
Neutral
- Market cap
- 10.64B
- P/E ratio
- -90.73
- Dividend yield
- 6.58%
- 52-week range
- — – —
- Volume
- 557
- Avg. volume
- 403
Price performance
GBLBY price history
1M range · 0 trading sessions · Daily adjusted prices
GBLBY does not have enough price history for the selected period.
Data unavailable
The requested market data was not found.
Latest GBLBY news
The latest Smart Investors Daily articles mentioning GBLBY.
Stock researchCompany · Overview
GBLBY research
Overview
Company profile and research snapshot.
Company profile
GROUPE BRUXLS LM UNSP/ADR
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- —
- Implied upside
- —
- Analysts
- —
| Date | Firm | Rating | Target |
|---|---|---|---|
| Jun 17, 2026 | ESN/CIC MARKET SOLUTIONS | Buy | — |
| Jun 7, 2026 | BAADER EUROPE / ALPHAVALUE | Buy | — |
| May 26, 2026 | ING FM | Buy | — |
| May 7, 2026 | DEGROOF PETERCAM | Buy | — |
| Feb 25, 2026 | KBC SECURITIES | Buy | — |
News briefing
No generated briefing is available yet.
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
